MovDisordV3, PascalFrancis, Corpus, bibRecord, 002585

Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG

Identifieur interne : 002585 ( PascalFrancis/Corpus ); précédent : 002584; suivant : 002586

Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG

Auteurs : Michael R. Pranzatelli ; Elizabeth D. Tate ; Marcel Kinshourne ; Verne S. Jr Caviness ; Bibhuti Mishra

Source :

Movement disorders [ 0885-3185 ] ; 2002.

RBID : Pascal:03-0038727

Descripteurs français

Pascal (Inist)
- Ataxie, Cervelet, Opsoclonie, Myoclonie, Immunoglobuline, Voie intraveineuse, Etude cas, Evolution, Récidive, Adulte, Chimiothérapie.

English descriptors

KwdEn :
- Adult, Ataxia, Case study, Cerebellum, Chemotherapy, Evolution, Immunoglobulins, Intravenous administration, Myoclonus, Opsoclonus, Relapse.

Abstract

We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 17`
A06				`@2 6`
A08	`01`	`1`	`ENG`	`@1 Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG`
A11	`01`	`1`		`@1 PRANZATELLI (Michael R.)`
A11	`02`	`1`		`@1 TATE (Elizabeth D.)`
A11	`03`	`1`		`@1 KINSHOURNE (Marcel)`
A11	`04`	`1`		`@1 CAVINESS (Verne S. JR)`
A11	`05`	`1`		`@1 MISHRA (Bibhuti)`
A14	`01`			`@1 The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine @2 Springfield, Illinois @3 USA @Z 1 aut. @Z 2 aut.`
A14	`02`			`@1 New School University and Tufts University @2 Winchester, Massachusetts @3 USA @Z 3 aut.`
A14	`03`			`@1 Massachusetts General Hospital @2 Boston, Massachusetts @3 USA @Z 4 aut.`
A14	`04`			`@1 Temple University @2 Philadelphia, Pennsylvania @3 USA @Z 5 aut.`
A20				`@1 1387-1390`
A21				`@1 2002`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000105559450430`
A44				`@0 0000 @1 © 2003 INIST-CNRS. All rights reserved.`
A45				`@0 20 ref.`
A47	`01`	`1`		`@0 03-0038727`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	`@0 We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.`
C02	`01`	`X`		`@0 002B17A01`
C03	`01`	`X`	`FRE`	`@0 Ataxie @5 01`
C03	`01`	`X`	`ENG`	`@0 Ataxia @5 01`
C03	`01`	`X`	`SPA`	`@0 Ataxia @5 01`
C03	`02`	`X`	`FRE`	`@0 Cervelet @5 02`
C03	`02`	`X`	`ENG`	`@0 Cerebellum @5 02`
C03	`02`	`X`	`SPA`	`@0 Cerebelo @5 02`
C03	`03`	`X`	`FRE`	`@0 Opsoclonie @5 04`
C03	`03`	`X`	`ENG`	`@0 Opsoclonus @5 04`
C03	`03`	`X`	`SPA`	`@0 Opsoclonación @5 04`
C03	`04`	`X`	`FRE`	`@0 Myoclonie @5 07`
C03	`04`	`X`	`ENG`	`@0 Myoclonus @5 07`
C03	`04`	`X`	`SPA`	`@0 Mioclonia @5 07`
C03	`05`	`X`	`FRE`	`@0 Immunoglobuline @5 10`
C03	`05`	`X`	`ENG`	`@0 Immunoglobulins @5 10`
C03	`05`	`X`	`SPA`	`@0 Inmunoglobulina @5 10`
C03	`06`	`X`	`FRE`	`@0 Voie intraveineuse @5 13`
C03	`06`	`X`	`ENG`	`@0 Intravenous administration @5 13`
C03	`06`	`X`	`SPA`	`@0 Vía intravenosa @5 13`
C03	`07`	`X`	`FRE`	`@0 Etude cas @5 16`
C03	`07`	`X`	`ENG`	`@0 Case study @5 16`
C03	`07`	`X`	`SPA`	`@0 Estudio caso @5 16`
C03	`08`	`X`	`FRE`	`@0 Evolution @5 17`
C03	`08`	`X`	`ENG`	`@0 Evolution @5 17`
C03	`08`	`X`	`SPA`	`@0 Evolución @5 17`
C03	`09`	`X`	`FRE`	`@0 Récidive @5 18`
C03	`09`	`X`	`ENG`	`@0 Relapse @5 18`
C03	`09`	`X`	`SPA`	`@0 Recaida @5 18`
C03	`10`	`X`	`FRE`	`@0 Adulte @5 20`
C03	`10`	`X`	`ENG`	`@0 Adult @5 20`
C03	`10`	`X`	`SPA`	`@0 Adulto @5 20`
C03	`11`	`X`	`FRE`	`@0 Chimiothérapie @5 23`
C03	`11`	`X`	`ENG`	`@0 Chemotherapy @5 23`
C03	`11`	`X`	`SPA`	`@0 Quimioterapia @5 23`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`03`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`03`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`03`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`04`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`04`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`04`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`05`	`X`	`FRE`	`@0 Cervelet pathologie @5 40`
C07	`05`	`X`	`ENG`	`@0 Cerebellar disease @5 40`
C07	`05`	`X`	`SPA`	`@0 Cerebelar enfermedad @5 40`
C07	`06`	`X`	`FRE`	`@0 Trouble neurologique @5 41`
C07	`06`	`X`	`ENG`	`@0 Neurological disorder @5 41`
C07	`06`	`X`	`SPA`	`@0 Trastorno neurológico @5 41`
C07	`07`	`X`	`FRE`	`@0 Oeil pathologie @5 45`
C07	`07`	`X`	`ENG`	`@0 Eye disease @5 45`
C07	`07`	`X`	`SPA`	`@0 Ojo patología @5 45`
C07	`08`	`X`	`FRE`	`@0 Oculomotricité syndrome @5 46`
C07	`08`	`X`	`ENG`	`@0 Oculomotor syndrome @5 46`
C07	`08`	`X`	`SPA`	`@0 Oculomotricidad síndrome @5 46`
C07	`09`	`X`	`FRE`	`@0 Mouvement involontaire @5 55`
C07	`09`	`X`	`ENG`	`@0 Involuntary movement @5 55`
C07	`09`	`X`	`SPA`	`@0 Movimiento involuntario @5 55`
C07	`10`	`X`	`FRE`	`@0 Voie administration @5 69`
C07	`10`	`X`	`ENG`	`@0 Route of administration @5 69`
C07	`10`	`X`	`SPA`	`@0 Vía administración @5 69`
N21				`@1 020`
N82				`@1 PSI`

Format Inist (serveur)

NO :	PASCAL 03-0038727 INIST
ET :	Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG
AU :	PRANZATELLI (Michael R.); TATE (Elizabeth D.); KINSHOURNE (Marcel); CAVINESS (Verne S. JR); MISHRA (Bibhuti)
AF :	The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine/Springfield, Illinois/Etats-Unis (1 aut., 2 aut.); New School University and Tufts University/Winchester, Massachusetts/Etats-Unis (3 aut.); Massachusetts General Hospital/Boston, Massachusetts/Etats-Unis (4 aut.); Temple University/Philadelphia, Pennsylvania/Etats-Unis (5 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2002; Vol. 17; No. 6; Pp. 1387-1390; Bibl. 20 ref.
LA :	Anglais
EA :	We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.
CC :	002B17A01
FD :	Ataxie; Cervelet; Opsoclonie; Myoclonie; Immunoglobuline; Voie intraveineuse; Etude cas; Evolution; Récidive; Adulte; Chimiothérapie
FG :	Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Cervelet pathologie; Trouble neurologique; Oeil pathologie; Oculomotricité syndrome; Mouvement involontaire; Voie administration
ED :	Ataxia; Cerebellum; Opsoclonus; Myoclonus; Immunoglobulins; Intravenous administration; Case study; Evolution; Relapse; Adult; Chemotherapy
EG :	Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Cerebellar disease; Neurological disorder; Eye disease; Oculomotor syndrome; Involuntary movement; Route of administration
SD :	Ataxia; Cerebelo; Opsoclonación; Mioclonia; Inmunoglobulina; Vía intravenosa; Estudio caso; Evolución; Recaida; Adulto; Quimioterapia
LO :	INIST-20953.354000105559450430
ID :	03-0038727

Links to Exploration step

Pascal:03-0038727

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG</title>
<author><name sortKey="Pranzatelli, Michael R" sort="Pranzatelli, Michael R" uniqKey="Pranzatelli M" first="Michael R." last="Pranzatelli">Michael R. Pranzatelli</name>
<affiliation><inist:fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tate, Elizabeth D" sort="Tate, Elizabeth D" uniqKey="Tate E" first="Elizabeth D." last="Tate">Elizabeth D. Tate</name>
<affiliation><inist:fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kinshourne, Marcel" sort="Kinshourne, Marcel" uniqKey="Kinshourne M" first="Marcel" last="Kinshourne">Marcel Kinshourne</name>
<affiliation><inist:fA14 i1="02"><s1>New School University and Tufts University</s1>
<s2>Winchester, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Caviness, Verne S Jr" sort="Caviness, Verne S Jr" uniqKey="Caviness V" first="Verne S. Jr" last="Caviness">Verne S. Jr Caviness</name>
<affiliation><inist:fA14 i1="03"><s1>Massachusetts General Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mishra, Bibhuti" sort="Mishra, Bibhuti" uniqKey="Mishra B" first="Bibhuti" last="Mishra">Bibhuti Mishra</name>
<affiliation><inist:fA14 i1="04"><s1>Temple University</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0038727</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 03-0038727 INIST</idno>
<idno type="RBID">Pascal:03-0038727</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002585</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG</title>
<author><name sortKey="Pranzatelli, Michael R" sort="Pranzatelli, Michael R" uniqKey="Pranzatelli M" first="Michael R." last="Pranzatelli">Michael R. Pranzatelli</name>
<affiliation><inist:fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tate, Elizabeth D" sort="Tate, Elizabeth D" uniqKey="Tate E" first="Elizabeth D." last="Tate">Elizabeth D. Tate</name>
<affiliation><inist:fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kinshourne, Marcel" sort="Kinshourne, Marcel" uniqKey="Kinshourne M" first="Marcel" last="Kinshourne">Marcel Kinshourne</name>
<affiliation><inist:fA14 i1="02"><s1>New School University and Tufts University</s1>
<s2>Winchester, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Caviness, Verne S Jr" sort="Caviness, Verne S Jr" uniqKey="Caviness V" first="Verne S. Jr" last="Caviness">Verne S. Jr Caviness</name>
<affiliation><inist:fA14 i1="03"><s1>Massachusetts General Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mishra, Bibhuti" sort="Mishra, Bibhuti" uniqKey="Mishra B" first="Bibhuti" last="Mishra">Bibhuti Mishra</name>
<affiliation><inist:fA14 i1="04"><s1>Temple University</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Ataxia</term>
<term>Case study</term>
<term>Cerebellum</term>
<term>Chemotherapy</term>
<term>Evolution</term>
<term>Immunoglobulins</term>
<term>Intravenous administration</term>
<term>Myoclonus</term>
<term>Opsoclonus</term>
<term>Relapse</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Ataxie</term>
<term>Cervelet</term>
<term>Opsoclonie</term>
<term>Myoclonie</term>
<term>Immunoglobuline</term>
<term>Voie intraveineuse</term>
<term>Etude cas</term>
<term>Evolution</term>
<term>Récidive</term>
<term>Adulte</term>
<term>Chimiothérapie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>17</s2>
</fA05>
<fA06><s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>PRANZATELLI (Michael R.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>TATE (Elizabeth D.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>KINSHOURNE (Marcel)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>CAVINESS (Verne S. JR)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>MISHRA (Bibhuti)</s1>
</fA11>
<fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>New School University and Tufts University</s1>
<s2>Winchester, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Massachusetts General Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Temple University</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>1387-1390</s1>
</fA20>
<fA21><s1>2002</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000105559450430</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>20 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0038727</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17A01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Ataxie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Ataxia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Ataxia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Cervelet</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Cerebellum</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Cerebelo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Opsoclonie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Opsoclonus</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Opsoclonación</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Myoclonie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Myoclonus</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Mioclonia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Immunoglobuline</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Immunoglobulins</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Inmunoglobulina</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Voie intraveineuse</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Intravenous administration</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Vía intravenosa</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Case study</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Evolution</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Evolution</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Evolución</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Récidive</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Relapse</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Recaida</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Adulte</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Adult</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Adulto</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>23</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>23</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Cervelet pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Cerebellar disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Cerebelar enfermedad</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Oeil pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Oculomotricité syndrome</s0>
<s5>46</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Oculomotor syndrome</s0>
<s5>46</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Oculomotricidad síndrome</s0>
<s5>46</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>55</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>55</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>55</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Voie administration</s0>
<s5>69</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Route of administration</s0>
<s5>69</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Vía administración</s0>
<s5>69</s5>
</fC07>
<fN21><s1>020</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 03-0038727 INIST</NO>
<ET>Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG</ET>
<AU>PRANZATELLI (Michael R.); TATE (Elizabeth D.); KINSHOURNE (Marcel); CAVINESS (Verne S. JR); MISHRA (Bibhuti)</AU>
<AF>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine/Springfield, Illinois/Etats-Unis (1 aut., 2 aut.); New School University and Tufts University/Winchester, Massachusetts/Etats-Unis (3 aut.); Massachusetts General Hospital/Boston, Massachusetts/Etats-Unis (4 aut.); Temple University/Philadelphia, Pennsylvania/Etats-Unis (5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2002; Vol. 17; No. 6; Pp. 1387-1390; Bibl. 20 ref.</SO>
<LA>Anglais</LA>
<EA>We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.</EA>
<CC>002B17A01</CC>
<FD>Ataxie; Cervelet; Opsoclonie; Myoclonie; Immunoglobuline; Voie intraveineuse; Etude cas; Evolution; Récidive; Adulte; Chimiothérapie</FD>
<FG>Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Cervelet pathologie; Trouble neurologique; Oeil pathologie; Oculomotricité syndrome; Mouvement involontaire; Voie administration</FG>
<ED>Ataxia; Cerebellum; Opsoclonus; Myoclonus; Immunoglobulins; Intravenous administration; Case study; Evolution; Relapse; Adult; Chemotherapy</ED>
<EG>Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Cerebellar disease; Neurological disorder; Eye disease; Oculomotor syndrome; Involuntary movement; Route of administration</EG>
<SD>Ataxia; Cerebelo; Opsoclonación; Mioclonia; Inmunoglobulina; Vía intravenosa; Estudio caso; Evolución; Recaida; Adulto; Quimioterapia</SD>
<LO>INIST-20953.354000105559450430</LO>
<ID>03-0038727</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002585 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002585 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:03-0038727
   |texte=   Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG

Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri